Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.429 USD | +4.72% | -2.21% | -8.80% |
05-02 | Cyclacel Pharmaceuticals, Inc. announced that it has received $8.000001 million in funding | CI |
04-30 | Top Midday Gainers | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.80% | 3.06M | |
+2.46% | 108B | |
+9.64% | 105B | |
+1.57% | 23.46B | |
-11.82% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.76% | 17.19B | |
+5.92% | 13.99B | |
+35.12% | 12.53B |
- Stock Market
- Equities
- CYCC Stock
- News Cyclacel Pharmaceuticals, Inc.
- Oppenheimer Adjusts Cyclacel Pharmaceuticals Price Target to $8 From $10, Maintains Outperform Rating